At the beginning of each month, we look back and share which companies have announced new funding rounds. Below is May 2021’s round-up. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet…
You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.
An estimated 5 million women in the U.S. suffer from symptoms of uterine fibroids, and an estimated 3 million women are inadequately treated by current medical therapy and require further treatment. Uterine fibroids are noncancerous tumors that develop in or on the muscular walls of the uterus and are among the most common reproductive tract tumors in women. In addition to an individual’s genetic…
Debates over women’s health have long been contentious, but have also resulted in significant improvements in areas like equitable access to health care and survivorship. But the overall picture remains far from perfect. For example, the United States still has the highest rate of maternal death among high-income countries, particularly among African American women. As the United States Supreme Court prepares to…
Toronto-based femtech startup Undu Wearables has recently launched their unique wearable menstrual pain management products across Canada. Period pain impacts 84% of women resulting in 9 days of productivity lost every year. Yet people looking for relief from menstrual pain have felt that this problem hasnot been adequately addressed and are looking for non-invasive options. Undu’s co-founders Robin Linton, Katherine Porter and…
Women’s Health Biotech Celmatix focused uniquely on ovarian biology has announced the appointment of Dr. Stephen Palmer as Chief Scientific Officer. Dr. Palmer had previously joined the company’s Scientific Advisory Board earlier this year, on the heels of rapid progress with Celmatix’s lead AMHR2 agonist program and the out-licensing of PCOS targets from its multi-omics ovarian health platform. Dr. Palmer is a…
Hormone testing company Proov has reportedly received patent issue notification for a utility patent covering a method of determining that the fertile window is opened following a positive result for LH and determining that the fertile window is closed following a positive result for PdG when such results are observed on a lateral flow assay test. The patent further includes claims covering…
Overture Life, the IVF process automation startup has announced a $15M in a Series B round bringing its fundraising total to $37M. Octopus Ventures led the Series B round. Existing investors such as Khosla Ventures, Felicis Ventures, and Marc Benioff also participated in the round. Google Ventures, also participant in the round, made its first Spain-based investment. Overture Life wants to democratize…
